NovoCure (NVCR) Tax Rate Growth (5y) (2019 - 2026)
NovoCure (NVCR) Tax Rate Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | NovoCure | 2.02 Bn | 1.58 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,512.00 |
| Mar 31, 2026 | 4,827.00 |
| Dec 31, 2025 | -410.00 |
| Sep 30, 2025 | -4,004.00 |
| Jun 30, 2025 | -7,390.00 |
| Mar 31, 2025 | -18,127.00 |
| Dec 31, 2024 | -38,700.00 |
| Sep 30, 2024 | 684.00 |
| Jun 30, 2024 | 280,665.00 |
| Mar 31, 2024 | 2,063.00 |
| Dec 31, 2023 | 2,224.00 |
| Sep 30, 2023 | 5,038.00 |
| Jun 30, 2023 | 4,944.00 |
| Mar 31, 2023 | 1,434.00 |
| Dec 31, 2022 | 4,428.00 |
| Sep 30, 2022 | 2,890.00 |
| Jun 30, 2022 | 1,675.00 |
| Mar 31, 2022 | -7,070.00 |
| Dec 31, 2021 | 347.00 |
| Sep 30, 2021 | -1,418.00 |